Why the study?
What variables determine heparin kinetics and dosage requirements in patients with active thromboembolic disease?
What variables determine heparin kinetics and dosage requirements in patients with active thromboembolic disease?
Heparin dosage requirements vary significantly among patients and can be largely predicted by body weight, sex, smoking status, and time from symptom onset.
Answers are grounded in this paper and cite their sources.
May guide heparin dosing in thromboembolism; hypothesis-generating pending prospective validation.
A method to determine heparin kinetics and dosage requirements was examined in 20 patients with active thromboembolic disease. Pretreatment heparin sensitivities were determined to establish the relationship between heparin concentration and activated partial thromboplastin times (APTTs). After an initial bolus dose, serial APTTs were measured, heparin concentrations were estimated, and kinetic determinations followed. Heparin elimination rate, distribution volume, and clearance were used to calculate dosage requirements. There was a 500% range in pretreatment heparin sensitivities. Smokers had more rapid heparin elimination rates and t 1/2s than nonsmokers did. Men had more rapid drug clearances than women did. Body weight was related to heparin dosage requirements. Patients treated early after onset of symptoms required higher doses than patients in whom treatment was delayed. A multiple regression model was developed for heparin dosage requirements from body weight, sex, delay between onset of symptoms and treatment, and smoking. This statistical model explained 78% of the variance in heparin requirements.
No takes yet. Share an insight, caveat, or question.
Cipolle et al. (1981) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: